HeartSciences Inc. HSCSW NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score

28/100

1/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

HeartSciences Inc. (HSCSW) generated $-7.41M in operating cash flow for fiscal year 2025. After capital expenditures of $30.19K, free cash flow was $-7.44M.

Free cash flow margin was -171107.6% of revenue. Cash conversion ratio was 0.85x, suggesting some earnings are non-cash.

Criteria supported by this page:

HEALTH (0/100, Fail) — weak cash flow raises concerns about debt servicing
MOAT (0/100, Fail) — limited free cash flow weakens the competitive position
INCOME (10/100) — Cash conversion ratio was 0.85x suggests some earnings are non-cash items

Overall SharesGrow Score: 27/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

28/100

SG Score

View full scorecard →

✓

VALUE

100/100

Price-to-Earnings & upside

→ Valuation

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

0/100

Proven by this page

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

HeartSciences Inc. Cash Flow History

Metric	TTM	FY2025	FY2024	FY2023	FY2022
Operating Cash Flow	$-5.75B	$-7.41M	$-6.07M	$-5.77M	$-3.64M
Capital Expenditure	$-3.56M	$-30.19K	$-125.27K	$-18.31K	$-1.93K
Free Cash Flow	$-5.76B	$-7.44M	$-6.2M	$-5.79M	$-3.65M